Free Trial
→ Trump’s Plan May Undo 1933’s Biggest Financial Injustice (From American Hartford Gold) (Ad)tc pixel Free GEHC Stock Alerts

GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

GE HealthCare Technologies logo
$77.28 +1.55 (+2.04%)
As of 01:07 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

GE HealthCare Technologies - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Moderate Buy
Based on 12 Analyst Ratings
Sell
0
Hold
3
Buy
9

Based on 12 Wall Street analysts who have issued ratings for GE HealthCare Technologies in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 3 have given a hold rating, 8 have given a buy rating, and 1 has given a strong buy rating for GEHC.

Consensus Price Target

$88.55
14.58% Upside
According to the 12 analysts' twelve-month price targets for GE HealthCare Technologies, the average price target is $88.55. The highest price target for GEHC is $103.00, while the lowest price target for GEHC is $73.00. The average price target represents a forecasted upside of 14.58% from the current price of $77.28.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for GEHC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for GE HealthCare Technologies and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GEHC Analyst Ratings Over Time

TypeCurrent Forecast
9/8/24 to 9/8/25		1 Month Ago
8/9/24 to 8/9/25		3 Months Ago
6/10/24 to 6/10/25		1 Year Ago
9/9/23 to 9/8/24
Strong Buy
1 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
8 Buy rating(s)
8 Buy rating(s)
8 Buy rating(s)
6 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$88.55$88.55$88.27$95.00
Forecasted Upside14.58% Upside22.98% Upside19.42% Upside11.65% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

GEHC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

GEHC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

GE HealthCare Technologies Stock vs. The Competition

TypeGE HealthCare TechnologiesMedical CompaniesS&P 500
Consensus Rating Score
2.83
2.78
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside16.92% Upside16,050.12% Upside10.35% Upside
News Sentiment Rating
Positive News

See Recent GEHC News
Positive News
Positive News
Export to Excel
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside		Details
8/28/2025Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 UpgradeHold ➝ Strong-Buy
7/31/2025Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Joanne Wuensch
Joanne Wuensch
4 of 5 stars
Boost TargetBuy$89.00 ➝ $93.00+30.40%
7/31/2025Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Patrick Wood
Not Rated
Lower TargetEqual Weight$78.00 ➝ $74.00+3.21%
7/14/2025BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 Reiterated RatingBuy
5/5/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Graham Doyle
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
UpgradeSell ➝ Neutral$74.00 ➝ $73.00+3.50%
5/1/2025The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
D. Roman
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
Lower TargetBuy$94.00 ➝ $82.00+19.42%
5/1/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Larry Biegelsen
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
Lower TargetOverweight$103.00 ➝ $89.00+29.06%
5/1/2025Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Vijay Kumar
Vijay Kumar
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
Lower TargetOutperform$96.00 ➝ $85.00+22.20%
4/23/2025Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 Lower TargetOverweight$104.00 ➝ $88.00+35.41%
1/8/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 UpgradeHold ➝ Buy$95.00 ➝ $103.00+23.55%
9/30/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 Boost TargetBuy$100.00 ➝ $102.00+10.88%
9/9/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 Initiated CoverageNeutral$90.00+5.77%
8/1/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
E. Ridley-Day
Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating
UpgradeStrong-Buy
5/1/2024Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 Lower TargetNeutral$94.00 ➝ $86.00+10.45%
5/1/2024Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 Lower TargetBuy$110.00 ➝ $105.00+35.45%
4/1/2024Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 Boost TargetBuy$80.00 ➝ $110.00+22.82%
2/15/2024HSBC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		 Initiated CoverageBuy$100.00+20.24%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 01:02 PM ET.


Should I Buy GE HealthCare Technologies Stock? GEHC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, September 6, 2025. Please send any questions or comments about these GE HealthCare Technologies pros and cons to contact@marketbeat.com.

GE HealthCare Technologies
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

  • The current stock price is around $75, which may present a buying opportunity for investors looking for growth potential.
  • Recent upgrades from analysts, including a "strong-buy" rating from Zacks Research, indicate positive sentiment and confidence in the company's future performance.
  • The company reported earnings per share of $1.06, surpassing analysts' expectations, which reflects strong operational performance and profitability.
  • GE HealthCare Technologies Inc. has a solid market capitalization of approximately $34.34 billion, suggesting stability and a significant presence in the healthcare sector.
  • The firm has demonstrated revenue growth, with a year-over-year increase of 3.5%, indicating a positive trend in its business operations.

GE HealthCare Technologies
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in GE HealthCare Technologies Inc. for these reasons:

  • Analysts have mixed ratings, with some maintaining a "hold" rating, which may suggest uncertainty about the stock's future performance.
  • The company's price-to-earnings ratio of 15.41 may indicate that the stock is relatively expensive compared to its earnings, which could deter value-focused investors.
  • Recent price target reductions by analysts, such as Morgan Stanley lowering their target from $78 to $74, may signal concerns about the stock's short-term outlook.
  • The dividend yield is relatively low at 0.2%, which may not attract income-focused investors looking for higher returns from dividends.
  • The stock has experienced volatility, with a 52-week high of $94.80 and a low of $57.65, indicating potential risks associated with price fluctuations.

GEHC Forecast - Frequently Asked Questions

According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for GE HealthCare Technologies is $88.55, with a high forecast of $103.00 and a low forecast of $73.00.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GE HealthCare Technologies in the last year. There are currently 3 hold ratings, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GEHC shares.

According to analysts, GE HealthCare Technologies's stock has a predicted upside of 14.58% based on their 12-month stock forecasts.

Over the previous 90 days, GE HealthCare Technologies's stock had 1 upgrade by analysts.

GE HealthCare Technologies has been rated by research analysts at BTIG Research, Citigroup, Morgan Stanley, and Zacks Research in the past 90 days.

Analysts like GE HealthCare Technologies more than other "medical" companies. The consensus rating score for GE HealthCare Technologies is 2.83 while the average consensus rating score for "medical" companies is 2.78. Learn more on how GEHC compares to other companies.

Related Companies
Today's Ratings
Top-Rated Stocks
More Ratings Tools

This page (NASDAQ:GEHC) was last updated on 9/8/2025 by MarketBeat.com Staff
From Our Partners
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...
SmartAsset | Sponsoredtc pixel
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...
Paradigm Press | Sponsoredtc pixel
What Steve Bannon revealed about Trump’s gold play
A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...
Reagan Gold Group | Sponsoredtc pixel
BREAKING: The House just passed 3 pro-crypto bills!
THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here.
Crypto 101 Media | Sponsoredtc pixel
The Next Market Crash Could End Everything
There's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...
American Hartford Gold | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel